7 completed, 1 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 7, Unknown 1 |
Follow Weights and Measures: new trials by email Literature Review of Weights and Measures trials Research Report on Weights and Measures
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Efficacy Between ILM Forceps Internal limiting membrane (ILM) Peeling with Sharkskin Forceps, Internal limiting membrane (ILM) Peeling with Standard Forceps - Macular Holes, Epiretinal Membrane | Phase 4 | Unknown | University of British Columbia | 56 | 2025-07-01 | 2025-03-30 |
| Effects of Caffeine Ingestion on Morning Cognitive and Muscle Strength Measures in Males 300mg of of caffeine anhydrous in 3 capsules similar to PLACEBO in size and weight, Placebo, No Pill - Caffine, Placebo - Control | Phase 4 | Completed | Liverpool John Moores University | 15 | 2024-11-15 | 2026-03-13 |
| Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock Vasopressor Agent, Crystalloid Solutions, Invasive Blood Pressure Monitoring - Septic Shock, Septicemia | Phase 4 | Completed | Bozyaka Training and Research Hospital | 85 | 2019-12-02 | 2022-11-29 |
| Use of the xCELLigence System for Quantification of Bacterial Biofilm's Real Time Formation and Antibiotics Selection. SCALE AND ROOT PLANING, ADJUNTIVE ANTIBIOTICS, MICROBIAL SAMPLING - Chronic Periodontitis, Periodontal Bone Loss | Phase 4 | Completed | University of Valencia | 64 | 2019-02-08 | 2026-05-12 |
| A Clinical Trial to Study the Effect of Lycopene in Patients With Gum Disease and type2 Diabetes Mellitus Lycored soft gels Jagsonpal Pharma, Systemic 8mgms/day, Scaling and root planing - Positive Regulation of Oxidative Stress Process | Phase 4 | Completed | Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre | 40 | 2013-01-01 | 2014-10-13 |
| Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients Cefazolin 25 mg/kg body weight and Vancomycin hydrochloride, Cefazolin 30 mg/kg body weight - Congenital Heart Diseases, Aortic Valve Disorder | Phase 4 | Completed | Stanford University | 32 | 2012-02-01 | 2018-05-16 |
| Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up Eptifibatide, Placebo - Non ST Elevation Myocardial Infarction | Phase 4 | Completed | Medical University of Silesia | 140 | 2005-01-01 | 2013-10-31 |
| Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. Ziprasidone, Olanzapine, Scales - Schizophrenia | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 112 | 2003-04-01 | 2021-02-21 |
Periodontitis (2) · Alveolar Bone Loss (1) · Aortic Valve Disease (1) · Chronic Periodontitis (1) · Dental Plaque (1) · Diabetes Mellitus (1) · Dysbiosis (1) · Epiretinal Membrane (1) · Heart Defects, Congenital (1) · Intra-Abdominal Hypertension (1) · Non-ST Elevated Myocardial Infarction (1) · Retinal Perforations (1) · Schizophrenia (1) · Sepsis (1) · Shock, Septic (1)
Bozyaka Training and Research Hospital (1) · Liverpool John Moores University (1) · Medical University of Silesia (1) · Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Stanford University (1) · University of British Columbia (1) · University of Valencia (1)
Spain (2) · United States (2) · Canada (1) · India (1) · Poland (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Ben J Edwards, PHD (1) · Bryon McKay, MD, PhD (1) · Dr.Manasa Ambati, MDS(Perio) (1) · Kathleen Gutierrez, MD (1) · Miroslaw Wilczynski, MD, PhD (1)